Waardenburg syndrome
Waardenburg syndrome | |
---|---|
Other names | Klein–Waardenburg syndrome (type 3), Shah–Waardenburg syndrome (type 4) |
Facial features of Waardenburg syndrome type 1 (from Jan van der Hoeve's description, 1916) | |
Specialty | Medical genetics |
Waardenburg syndrome is a group of rare
The syndrome is caused by mutations in any of several genes that affect the
The estimated prevalence of Waardenburg syndrome is 1 in 42,000.[5][8] Types 1 and 2 are the most common, comprising approximately half and a third of cases, respectively, while type 4 comprises a fifth and type 3 less than 2% of cases.[8] An estimated 2–5% of congenitally deaf people have Waardenburg syndrome.[8] Descriptions of the syndrome date back to at least the first half of the 20th century, however it is named after Dutch ophthalmologist and geneticist Petrus Johannes Waardenburg, who described it in 1951.[9][10] Its subtypes were progressively discovered in the following decades and had genes attributed to them mostly in the 1990s and 2000s.
Signs and symptoms
Waardenburg syndrome has multiple different types with some variations in symptoms, and symptoms can vary among those with the same type. The two features consistent across all types of Waardenburg syndrome are some degree of congenital sensorineural hearing loss and some degree of pigmentation deficiencies, most consistently in the eyes.[11]
Type 1
Type 1 is characterised by congenital sensorineural hearing loss, pigmentary deficiencies of the hair such as a white lock of hair (poliosis) in the front-centre of the head or premature greying, pigmentary deficiencies of the eyes such as different-coloured eyes (complete heterochromia iridum), multiple colours in an eye (sectoral heterochromia iridum) or brilliant blue eyes, patches of skin depigmentation, and a wider gap between the inner corners of the eyes called telecanthus or dystopia canthorum. Other facial features associated with type 1 can include a high nasal bridge, a flat nose tip, a unibrow (synophrys), smaller edges of the nostrils (alae) or a smooth philtrum.[1]
Type 2
The difference that defines type 2 from type 1 is that patients do not have the wider gap between the inner corners of the eyes (telecanthus/dystopia canthorum). Sensorineural hearing loss tends to be more common and more severe in this type.
There have been two known patients identified with mutations in both copies of SNAI2 (classified as type 2D); these individuals presented with Waardenburg syndrome type 2 but did not have hair pigmentation deficiencies.[13]
When Waardenburg syndrome type 2 is caused by a mutation in
Type 3
Also known as Klein–Waardenburg syndrome, or Waardenburg–Klein syndrome, type 3 has the same symptoms as type 1 (and is caused by mutations in the same gene) but has additional symptoms that affect the arms and hands. These can include joint
Type 4
Also known as Shah–Waardenburg syndrome, or Waardenburg–Shah syndrome, type 4 has most of the same features as type 2 (i.e. no telecanthus, or apparent wider eye gap), but with the addition of
Type 4 can also be caused by a mutation in SOX10 (the same gene as in type 2E), in which it is known as type 4C; hearing loss is very common and severe in this type.[16]
PCWH
A mutation in SOX10, the gene involved in type 2E and type 4C, can sometimes result in the symptoms of both types (neurological symptoms, as sometimes seen in type 2E, and Hirschsprung's disease, as seen in type 4). When this happens, it is called peripheral demyelinating neuropathy–central dysmyelinating leukodystrophy–Waardenburg syndrome–Hirschsprung disease (PCWH).[17][18]
Cause
Waardenburg syndrome is caused by mutations in any of several genes that affect the operation of
The neural crest is a group of temporary migratory cells that are left over after the
Causes of subtypes
- Type 1 is caused by an autosomal dominant mutation in the gene
- Type 2 is caused by a mutation in any of a range of genes, the most common being MITF, when it is classed as type 2A.
- Type 2A is caused by an autosomal dominant mutation in the gene MITF.retinal pigment epithelial cells to divide and migrate. The involvement in osteoclasts explains why mutations in both copies of MITF can lead to bone hardening (osteopetrosis), as the osteoclasts are responsible for breaking down bone. MITF also activates transcription of tyrosinase, the enzyme that performs the first step in the creation of melanin (oxidising tyrosine). A mutation in a copy of MITF can also lead to Tietz syndrome, which is distinguished from Waardenburg syndrome by uniform albinism instead of patchy depigmentation.[5]
- Type 2B is caused by an autosomal dominant mutation in an unknown gene on chromosome 1 in the locus range of 1p21–1p13.3. The gene has been provisionally termed WS2B.[21][22]
- Type 2C is caused by an autosomal dominant mutation in an unknown gene on chromosome 8 in the locus of 8p23. The gene has been provisionally termed WS2C.[23][24]
- Type 2D is caused by an autosomal recessive mutation in both copies of the gene SNAI2. The study that discovered this association found that SNAI2 is activated by MITF as part of neural crest development, and this explained why mutations in MITF cause Waardenburg syndrome, as it results in a lack of activation of SNAI2. Mutations in a single copy of SNAI2 have also been found to cause patches of hair depigmentation (piebaldism) without any other symptoms.[25]
- Type 2E is caused by an autosomal dominant mutation in the gene SOX10.[4]
- Rarely, a mutation in a gene other than those currently known may be responsible for a Waardenburg syndrome with features of type 2. This is usually initially classified as simply type 2 but may be given its own subtype once a gene or locus is identified and established.[7]
- Type 2A is caused by an autosomal dominant mutation in the gene MITF.
- Type 3 is caused by a mutation in the gene paired domain region of the gene has been documented to have this effect.[26][5] However, no major correlation has been found between type of mutation and disease severity. Severity tends to be dictated by mutations in other genes (epistasis), as evidenced by distinct familial patterns in severity not tied to Waardenburg mutation type.[5] Mutations in both copies of PAX3 have sometimes led to death before or shortly after birth, and mice with loss-of-function mutations in both copies of the gene do not survive.[5]
- Type 4 is caused by a mutation in any of a range of genes, the most common being SOX10, when it is classed as type 4C.
- Type 4A is caused by an autosomal dominant or autosomal-recessive mutation in the gene EDNRB.[15]
- Type 4B is caused by an autosomal dominant or autosomal-recessive mutation in the gene EDN3.[27]
- Type 4C is caused by an autosomal dominant or autosomal-recessive mutation in the gene SOX10, the same gene as in type 2E.[16]
- Type 4A is caused by an autosomal dominant or autosomal-recessive mutation in the gene
A study was done on a rare case of a double heterozygous child with each parent having only single mutations in MITF or PAX3. The effect of double heterozygous mutations in the genes MITF and PAX3 in WS1 and WS2 can increase the pigment-affected symptoms. It leads to the conclusion that the double mutation of MITF is associated with the extremity of Waardenburg syndrome and may affect the phenotypes or symptoms of the syndrome.[28]
Classification table
Type | OMIM
|
Gene | Locus | Inheritance |
---|---|---|---|---|
Type 1 (WS1) | 193500 | PAX3 | 2q36.1[29] | Autosomal dominant |
Type 2A (WS2A, originally WS2) | 193510 | MITF | 3p14.1–p12.3 | Autosomal dominant |
Type 2B (WS2B) | 600193 | WS2B | 1p21–p13.3 | Autosomal dominant |
Type 2C (WS2C) | 606662 | WS2C | 8p23 | Autosomal dominant |
Type 2D (WS2D) | 608890 | SNAI2 | 8q11 | Autosomal recessive |
Type 2E (WS2E) | 611584 | SOX10 | 22q13.1 | Autosomal dominant |
Type 3 (WS3) | 148820 | PAX3 | 2q36.1 | Autosomal dominant or autosomal recessive |
Type 4A (WS4A) | 277580 | EDNRB
|
13q22 | Autosomal dominant or autosomal recessive |
Type 4B (WS4B) | 613265 | EDN3
|
20q13 | Autosomal dominant or autosomal recessive |
Type 4C (WS4C) | 613266 | SOX10 | 22q13.1 | Autosomal dominant |
Treatment
There is currently no treatment or cure for Waardenburg syndrome. The symptom most likely to be of practical importance is deafness, and this is treated as any other irreversible deafness would be. In marked cases, there may be cosmetic issues. Other abnormalities (neurological, structural, Hirschsprung's disease) associated with the syndrome are treated symptomatically.
Epidemiology
The prevalence of all types of Waardenburg syndrome is estimated at 1 in 42,000.[5][8] Types 1 and 2 are by far the most common, with type 1 appearing to be slightly more common.[30][31] In a 2015 review looking at 417 patients, type 1 was found to be the most common type, encompassing around half of all cases (47%), while type 2 was the second-most common type, encompassing around a third (33%).[8] The vast majority (around 85%) of type 2 cases are type 2A.[8] The prevalence of type 2B is unknown, as it was only reported in one 1996 study.[22] Type 2C has so far only been found in one Italian family,[23][24] and type 2D had only been found in 2 unrelated patients as of 2018[update].[13][8][32] The number of known cases of type 2E that involved neurological abnormalities was reported to be 23 as of 2017[update],[33] while the number of the rest is unknown. Type 3 is rarer than types 1, 2 and 4,[34] comprising less than 2% of cases.[8] Type 4 appears to encompass around a fifth of cases (19%). Of its subtypes, type 4C is by far the most common (about 71% of type 4), followed by type 4A (19%) and type 4B (10%).[8]
It is estimated that Waardenburg syndrome is present in 2–5% of congenitally deaf people. Congenital deafness comprises around half of deafness as a whole.[8] About 1 in 30 students in schools for the deaf have Waardenburg syndrome. The variable presentation of the syndrome makes it difficult to arrive at precise figures for its prevalence.[8]
History
Early descriptions
In 1916, Dutch ophthalmologist Jan van der Hoeve (1878–1952) described a pair of twin girls with deafness and a particular type of blepharophimosis, believed to be the dystopia canthorum found in Waardenburg syndrome types 1 and 3.[8][35] Blepharophimosis describes eyelids which are underdeveloped such that they permanently cover part of the eyes.
In 1926, German physician Irmgard Mende described a family of four generations in which five children had symptoms of depigmentation of hair, skin and eyes, deafness and a "mongoloid" appearance. (Waardenburg later attributed this description to the dystopia canthorum.)[36][35] This later led to the synonym Mende syndrome being recorded in some databases.[11][37]
In 1929, Dutch physician K. T. A. Halbertsma described a familial pattern to dystopia canthorum,[38][35] and in 1930, Italian physician Vincenzo Gualdi[39] (1891–1976) also confirmed a hereditary pattern to dystopia canthorum.[36] This later led to the synonym Van der Hoeve–Halbertsma–Waardenburg–Gualdi syndrome being recorded in some databases.[11]
In 1947, Swiss ophthalmologist David Klein (1908–1993) first reported a patient with bilateral deafness, pigmentation deficiencies, characteristic facial features and malformation of the arms. Although this was the first full description of a patient with Waardenburg syndrome type 3, contemporary clinicians did not consider the syndrome he described to be the same as that described by Waardenburg four years later, in part due to how severe the arm malformations were in his patient.[40]
The syndrome was first fully formalised and described by Dutch ophthalmologist and geneticist Petrus Johannes Waardenburg (1886–1979) in 1951.[9][10] The condition he described is now categorised as Waardenburg syndrome type 1.
Descriptions of subtypes
Type 2 was first established in 1971 when a study noticed that some Waardenburg syndrome patients did not have dystopia canthorum.[7][41] A 1977 study confirmed a familial pattern to this other presentation.[7] Two 1994 studies first confirmed a link between this type of Waardenburg syndrome and mutations in the MITF gene (now classed as type 2A), located on chromosome 3 at locus 3p14.1–p12.3.[7]
Type 2B was first established in 1994 when the same study which found mutations in MITF in patients with Waardenburg syndrome type 2 also found that some patients did not have any mutations in this region.[21][42] A second 1994 study found a link to chromosome 1 in the locus 1p21–p13.3. This became known as type 2B of the condition (with the gene designated WS2B), however it has not been documented since, and the gene responsible remains unknown.[21][22]
Type 2C was established in 2001 when a study of an Italian family with Waardenburg syndrome type 2 features found that they were due to an unknown gene on chromosome 8 at locus 8q23 that had been broken by a chromosomal translocation. The study established a provisional name for the gene, WS2C. However, mutations in this region in Waardenburg syndrome patients have not been found since.[23][24]
Type 2D was established in 2002 when a study looking to find mutations in the human version of the SNAI2 gene, known to cause depigmentation in mice, found deletions of both copies of this gene in two unrelated individuals with Waardenburg syndrome type 2. Mutations in both copies of this gene have not been found in those with Waardenburg syndrome type 2 since.[8]
Type 2E was first established in 1996 when a study identified a girl with symptoms of Waardenburg syndrome type 2 but with additional underdevelopment of the front of the eye, leading to blindness. In 1999, it was found that she had a mutation in her SOX10 gene, and later studies confirmed the association between mutations in this gene and this phenotype, as well as neurological symptoms such as developmental delay.[4]
Type 3 was first given its name by Goodman et al. in 1981, in collaboration with Klein, in which they established the association with arm abnormalities first reported by Klein in 1947.[40] Mutations in PAX3 were first linked to this phenotype in 1992.[2]
The comorbidity with Hirschsprung's disease, which would later constitute type 4, was first noticed in various studies in the 1970s. Indian paediatrician Krishnakumar Shah and his associates first outlined the syndrome as a possible variant of Waardenburg syndrome in 1981.[43] The variant was first attributed to a mutation in EDNRB in 1994 (now classed as type 4A).[3] Type 4B was established in 1996 when mutations in EDN3 were found to lead to this type of Waardenburg syndrome,[27] and type 4C was first established in 1998 when mutations in SOX10 were also found to lead to this type.[16]
Society and culture
Popular culture
- The 2001 novel Shock by Robin Cook mentions a character with the disorder.[44]
- Enzo MacLeod, protagonist of Peter May's 2006–2017 book series The Enzo Files, has Waardenburg syndrome. His eyes are different colors, and he has a white streak in his hair.[45][46]
- In the 2011 Bones "The Signs in the Silence", the team must solve a case in which the suspected killer has Waardenburg syndrome.[47]
- The 2013 book Reconstructing Amelia by Kimberly McCreight features several characters with Waardenburg symptoms.[48]
- The 2014 book Closer Than You Think by Karen Rose features three characters, siblings, with Waardenburg syndrome.[49]
- The 2017 book Murder at the Mayan Temple by M.J. Mandrake features several characters with Waardenburg syndrome.better source needed]
- The 2019 novel The Whisper Network by Chandler Baker uses the syndrome as a plot point.[citation needed]
Notable people
- Canadian YouTube vlogger Stef Sanjati has Waardenburg syndrome type 1.[51]
Other animals
Waardenburg syndrome type 2A (with a mutation in MITF) has been found in dogs,
Lethal white syndrome is a syndrome in horses caused by mutations in both copies of EDNRB. It leads to death from intestinal pseudo-obstruction due to Hirschsprung's disease. A mutation in a single copy of EDNRB, however, as in Waardenburg syndrome type 4A, produces the patchy white overo coat with deafness.[59]
Ferrets with Waardenburg syndrome have a small white stripe along the top or back of the head and sometimes down the back of the neck (known as a "blaze" coat pattern), or a solid-white head from nose to shoulders (known as a "panda" coat pattern). Affected ferrets often have a very slightly flatter skull and wider-set eyes than healthy ferrets. As healthy ferrets have poor hearing, deafness may only be detected by lack of reaction to loud noises. As this is an inherited disorder, affected animals should not be used for breeding. A study of the correlation between coat variations and deafness in European ferrets found, "All (n=27) panda, American panda, and blaze ferrets were deaf."[60]
See also
- Chédiak–Higashi syndrome, a similar syndrome including immunodeficiency and peripheral neuropathy
- Tietz syndrome, a condition similar to Waardenburg syndrome type 2 involving uniform albinism (caused by mutations in MITF)
- Vogt–Koyanagi–Harada disease, an autoimmune disease causing uveitis, patchy depigmentation and inner ear symptoms
References
- ^ a b c d "OMIM Entry - # 193500 - WAARDENBURG SYNDROME, TYPE 1; WS1". omim.org. Retrieved 2019-12-07.
- ^ a b c d e "OMIM Entry - # 148820 - WAARDENBURG SYNDROME, TYPE 3; WS3". omim.org. Retrieved 2019-12-07.
- ^ a b c d "OMIM Entry - # 277580 - WAARDENBURG SYNDROME, TYPE 4A; WS4A". omim.org. Retrieved 2019-12-07.
- ^ a b c d "OMIM Entry - # 611584 - WAARDENBURG SYNDROME, TYPE 2E; WS2E". omim.org. Retrieved 2019-12-07.
- ^ S2CID 12278025.
- ^ a b "Neural Crest Development - Embryology". embryology.med.unsw.edu.au. Retrieved 2019-12-13.
- ^ a b c d e f g h "OMIM Entry - # 193510 - WAARDENBURG SYNDROME, TYPE 2A; WS2A". omim.org. Retrieved 2019-12-07.
- ^ S2CID 23834634.
- ^ PMID 30559775.
- ^ PMID 14902764.
- ^ a b c "Waardenburg syndrome | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. Retrieved 2018-04-17.
- ^ "Waardenburg syndrome". Genetics Home Reference. October 2012.
- ^ a b "OMIM Entry - # 608890 - WAARDENBURG SYNDROME, TYPE 2D; WS2D". omim.org. Retrieved 2019-12-07.
- PMID 22848661.
- ^ S2CID 24530898.
- ^ a b c "OMIM Entry - # 613266 - WAARDENBURG SYNDROME, TYPE 4C; WS4C". omim.org. Retrieved 2019-12-07.
- ^ "Orphanet: Search a disease". www.orpha.net. Retrieved 2019-12-10.
- PMID 16504559.
- PMID 26043871.
- PMID 28263292.
- ^ a b c "OMIM Entry - % 600193 - WAARDENBURG SYNDROME, TYPE 2B; WS2B". www.omim.org. Retrieved 2019-12-23.
- ^ OSTI 133315.
- ^ a b c "OMIM Entry - % 606662 - WAARDENBURG SYNDROME, TYPE 2C; WS2C". omim.org. Retrieved 2019-12-07.
- ^ S2CID 24411957.
- S2CID 33811699.
- S2CID 24025063.
- ^ a b "OMIM Entry - # 613265 - WAARDENBURG SYNDROME, TYPE 4B; WS4B". omim.org. Retrieved 2019-12-07.
- S2CID 34173541.
- S2CID 36749688.
- ^ "Orphanet: Waardenburg syndrome type 1". www.orpha.net. Retrieved 2019-12-10.
- ^ "Waardenburg syndrome type II" (PDF). Orphanet. 2005. Archived from the original (PDF) on 24 April 2021. Retrieved 10 December 2019.
- PMID 30561083.
- S2CID 13676694.
- ^ "Orphanet: Waardenburg syndrome type 3". www.orpha.net. Retrieved 2019-12-10.
- ^ S2CID 10163905.
Waardenburg (1951, 1957, 1961) has expressed the belief that all these cases of uncomplicated blepharophimosis do in fact belong to his syndrome and that this type of dystopia canthorum does not occur as a separate trait. ... With regard to Mende's cases, [Waardenburg] believes that the 'mongoloid component' in these patients was in actuality due to dystopia canthorum.
- ^ PMID 6340503.
- ISBN 978-0-7817-5443-9.
- ^ "Over twee op elkaar gelijkende, in wezen echter verschillende aangeboren oogafwijkingen". Nederlands Tijdschrift voor Geneeskunde (in Dutch). 2009-12-02. Retrieved 2019-12-10.
- ^ Annuario del Ministero dell'Educazione nazionale (in Italian). Provveditorato generale dello Stato. 1935. p. 142.
- ^ PMID 7091186.
- PMID 5006208.
- S2CID 2913481.
- PMID 7264803.
- ISBN 978-1-4472-1796-1.
- ISBN 978-1-78206-885-3.
- ISBN 978-1-78206-887-7.
- ^ "Bones Recap 6.21 "The Signs in the Silence" – Persephone Magazine". Archived from the original on 2011-10-11. Retrieved 2019-12-14.
- ISBN 978-1-4711-2944-5.
- ISBN 978-0-7553-8999-5.
- ^ mynonie. "Meet a nice sleuth". Amazon.com. Retrieved 2019-12-14.
- ^ Edwards, Lucy (2018). "'I get you're transgender, but what's up with your face?'". BBC News. Retrieved 2018-01-28.
- S2CID 16725018.
- PMID 26664958.
- PMID 20808581.
- ISBN 9780811819299.
- PMID 484594.
The deaf, blue-eyed, white cat, noted by Bree [1829] and by Darwin [1892] and studied histologically at the turn of the century [Alexander, 1900], has a variable clinical and histologic picture, due to either of two autosomal dominant genes ... These pleiotropic effects of single genes may be explained by effects on the neural crest cells involved in the origin of all the tissues affected in Waardenburg syndrome [Weston, 1969].
- PMID 25085922.
- PMID 21273305.
- PMID 19912043.
- PMID 24739114.
External links
- GeneReviews/NCBI/NIH/UW entry on Waardenburg Syndrome Type I
- OMIM Genetic disorder catalog — Waardenburg syndrome